Greenland Mines Ltd — fact timeline

Greenland Mines Ltd entered into Share Exchange Agreement with AnorTech Inc. (effective 2026-06-15).

“On June 15, 2026, Greenland Mines Ltd. (the “Company”) entered into a Share Exchange Agreement (the “Agreement”) with AnorTech Inc. (“AnorTech”), a TSXV traded company, pursuant to which the Company agreed to acquire 19,958,503 common shares of AnorTech, representing approximately 9.9% of AnorTech’s issued and outstanding common shares on a post-closing basis.”

Greenland Mines Ltd shareholders approved Approval of one or more amendments to the Certificate of Incorporation to effect reverse stock splits with exchange ratios between 1-for-2 and 1-for-50 at the 2026-06-18 meeting.

“Set forth below are the final voting results for the Reverse Stock Split Proposal. Proposal 1. Approval of the Reverse Stock Split. For Against Abstain Broker Non-Votes 42,878,771 2,210,259 22,102 0”

Greenland Mines Ltd entered into Securities Purchase Agreement with three investors valued at $3,750,000 (effective 2026-06-15).

“On June 15, 2026, Greenland Mines Ltd. (the “Company”) entered into a Securities Purchase Agreement (the “Agreement”) with three investors pursuant to which the Company agreed to issue and sell to the investors, at a closing, a total of 15,000,000 shares of the Company’s common stock for total proceeds of $3,750,000.”

Greenland Mines Ltd entered into Agreement and Plan of Merger with Neo North Star Resources, Inc, a Delaware corporation ("Neo North Star") and the stockholders of Neo North Star valued at $35,000,000 payable in the form of $20,000,000 in cash and $15,000,000 in newly issued shares (effective 2026-05-20).

“On May 20, 2026, Greenland Mines Ltd (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Neo North Star Resources, Inc, a Delaware corporation (“Neo North Star”) and the stockholders of Neo North Star.”

Greenland Mines Ltd: Company changed its name from Klotho Neurosciences, Inc. to Greenland Mines Ltd via a Certificate of Ownership and Merger filed under Section 253(b) of the DGCL (effective 2026-03-11).

“On March 11, 2026, the registrant, then known as Klotho Neurosciences, Inc. (the “Company”) filed a Certificate of Ownership and Merger with the Secretary of State of the State of Delaware to merge the Company’s newly formed GML Subsidiary Corp. into the Company, with the Company being the surviving entity and effectuating, pursuant to Section 253(b) of the Delaware General Corporation Law, a change in the Company’s name from Klotho Neurosciences, Inc. to Greenland Mines Ltd.”

Greenland Mines Ltd: Designated Series C Preferred Stock, authorizing 50,000 shares with dividend, voting, and conversion rights (effective 2026-03-04).

“On March 4, 2026, the Board of Directors of the Company, pursuant to a Certificate of Designation, designated a new series of the Company’s preferred stock to be known as Series C Preferred Stock (the “Certificate of Designation”).”

Greenland Mines Ltd entered into Agreement and Plan of Merger with Greenland Mines Corp., a Delaware corporation valued at 47,000 newly issued shares of the Company’s Series C Preferred Stock (effective 2026-03-04).

“On March 4, 2026, Klotho Neurosciences, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Greenland Mines Corp., a Delaware corporation (“Greenland Mines”).”

Greenland Mines Ltd completed an acquisition involving Greenland Mines Corp. for 47,000 newly issued shares of the Company’s Series C Preferred Stock (closed 2026-03-04).

“with Greenland Mines being the surviving entity. Pursuant to the Merger Agreement, as consideration for the Merger, the stockholders of Greenland Mines will receive a total of 47,000 newly issued shares of the Company’s Series C Preferred Stock. In addition, the stockholders of Greenland Mines have the right to designate one individual to join the Company’s”

Greenland Mines Ltd issued warrants to purchase up to 34,551,939 shares of common stock of warrant to the Purchasers for aggregate gross proceeds of approximately $7,750,000 (included in the same private placement).

“On March 2, 2026, Klotho Neurosciences, Inc. (the “Company”) closed and completed the private placement (the “Financing”) contemplated by that certain Securities Purchase Agreement, dated February 19, 2026, by and among the Company and the purchasers named therein (the “Purchasers”). A copy of the Securities Purchase Agreement is included as Exhibit 10.1 to the Company’s Form 8-K filed on February 24, 2026. At the closing of the Offering, the Company issued to the Purchasers an aggregate of 34,551,939 shares of the Company’s common stock and warrants to purchase up to an aggregate of 34,551,939 shares of Common Stock (the “Warrants”).The sale of the securities resulted in aggregate gross proceeds to the Company of approximately $7,750,000.”

Greenland Mines Ltd issued 34,551,939 shares of common stock of common stock to the Purchasers for aggregate gross proceeds of approximately $7,750,000.

“On March 2, 2026, Klotho Neurosciences, Inc. (the “Company”) closed and completed the private placement (the “Financing”) contemplated by that certain Securities Purchase Agreement, dated February 19, 2026, by and among the Company and the purchasers named therein (the “Purchasers”). A copy of the Securities Purchase Agreement is included as Exhibit 10.1 to the Company’s Form 8-K filed on February 24, 2026. At the closing of the Offering, the Company issued to the Purchasers an aggregate of 34,551,939 shares of the Company’s common stock and warrants to purchase up to an aggregate of 34,551,939 shares of Common Stock (the “Warrants”).The sale of the securities resulted in aggregate gross proceeds to the Company of approximately $7,750,000.”

Greenland Mines Ltd entered into Securities Purchase Agreement with 10 investors (effective 2026-02-19).

“On February 19, 2026, Klotho Neurosciences, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Agreement”) with 10 investors pursuant to which the Company agreed to issue and sell to the investors, at a closing, a total of 34,551,939 shares of the Company’s common stock at the Nasdaq official closing price for the prior five trading days of $0.2243 per share.”

Greenland Mines Ltd entered into Securities Purchase Agreement with Sigma9 Capital, Ltd. valued at $4,400.00 per share (effective 2025-12-02).

“On December 2, 2025, Klotho Neurosciences, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Agreement”) with an investor, Sigma9 Capital, Ltd., pursuant to which the Company agreed to issue and sell to the investor 3,400 shares of a new class of the Company’s preferred stock to be designated as Series C Preferred Stock, at a price of $4,400.00 per share.”

Greenland Mines Ltd issued 3,400 shares of preferred stock to Sigma9 Capital, Ltd. for $4,400.00 per share.

“On December 2, 2025, the Company entered into a Securities Purchase Agreement (the “Agreement”) with Sigma9 Capital, Ltd., pursuant to which the Company agreed to issue and sell to the investor 3,400 shares of a new class of the Company’s preferred stock to be designated as Series C Preferred Stock, at a price of $4,400.00 per share.”

Greenland Mines Ltd received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“September 19, 2025, Klotho Neurosciences, Inc. (the “Company”) received a delinquency notification letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) due to the failure of the Company’s common stock to maintain a minimum bid price of $1 per share for 30 consecutive business days as required by Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until March 18, 2026, to regain compliance. To regain compliance, prior to March 18, 2026, the closing bid price of the Company’s common stock must be a”

Greenland Mines Ltd received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“July 14, 2025, Klotho Neurosciences, Inc. (the “Company”), received a letter from the Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum $1.00 bid price under NASDAQ Listing Rule 5550(a)(2), and the minimum stockholders’ equity threshold of $2.5 million under Listing Rule 5550(b)(1). In addition, on July 14. 2025, Nasdaq approved the Company’s application to “phase down” the listing of its common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market. The Company’s common stock will continue to trade under”

Greenland Mines Ltd received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“July 14, 2025, Klotho Neurosciences, Inc. (the “Company”), received a letter from the Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum $1.00 bid price under NASDAQ Listing Rule 5550(a)(2), and the minimum stockholders’ equity threshold of $2.5 million under Listing Rule 5550(b)(1). In addition, on July 14. 2025, Nasdaq approved the Company’s application to “phase down” the listing of its common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market. The Company’s common stock will continue to trade under”

Greenland Mines Ltd received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“October 15, 2024, the Company received a delinquency notification letter (the “Notice”) from Nasdaq due to the Company’s non-compliance with Nasdaq Listing Rule 5450(a)(1). The Notice cited the fact that the bid price of the Company’s common stock had closed at less than $1 per share over the previous 30 consecutive business days. B. On April 15, 2025, the Company received written notice (the “April 15 Notice”) from the Nasdaq stating that the Company has not regained compliance with the Rule. The April 15 Notice also stated that the Panel will consider this matter in their decision regarding”

Greenland Mines Ltd received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5450(b)(2)(A), 5810(c)(3)(D)).

“August 16, 2024, Klotho Neurosciences, Inc. (the “Company”) received two delinquency notification letters (the “Notices”) from The Nasdaq Stock Market LLC (“Nasdaq”) due to the Company’s non-compliance with Nasdaq Listing Rules 5450(b)(2)(C) and 5450(b)(2)(A). The Notices cite the Company for not being in compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) requirement, as set forth in Nasdaq Listing Rule 5450(b)(2)(C), and for not being in compliance with the minimum Market Value of Listed Securities (“MVLS”) requirement, as set forth in Nasdaq Listing Rule 5450(b)(2)(A)”

Greenland Mines Ltd received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A)).

“February 14, 2025, the Company received written notice (the “Delisting Notice”) from the Nasdaq Listing Qualifications Department stating that the Company has not regained compliance with the Rules and the Company’s securities will be delisted from The Nasdaq Global Markets (the “Delisting Determination”) unless the Company requests an appeal of this determination by February 21, 2025 pursuant to procedures set forth in Nasdaq Listing Rule 5800 Series. On February 21, 2025, the Company exercised its right to request a hearing to appeal the Delisting Determination and paid Nasdaq the applicable”

Greenland Mines Ltd received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(C)).

“February 14, 2025, the Company received written notice (the “Delisting Notice”) from the Nasdaq Listing Qualifications Department stating that the Company has not regained compliance with the Rules and the Company’s securities will be delisted from The Nasdaq Global Markets (the “Delisting Determination”) unless the Company requests an appeal of this determination by February 21, 2025 pursuant to procedures set forth in Nasdaq Listing Rule 5800 Series. On February 21, 2025, the Company exercised its right to request a hearing to appeal the Delisting Determination and paid Nasdaq the applicable”

Riad El-Dada was appointed as Director at Greenland Mines Ltd.

“On November 19, 2024, the Board of Directors of Klotho Neurosciences, Inc. (the “Company”) appointed Riad El-Dada to the Board of Director to fill a vacancy on the Board of Directors with a term expiring at the Company’s next Annual Meeting of Stockholders.”

Greenland Mines Ltd engaged BCRG Group as its auditor.

“On October 28, 2024, the board of directors of the Company resolved to engage the independent registered public accounting firm BCRG Group ("BCRG"), as the Company's new independent registered public accountants, which appointment BCRG has accepted.”

Greenland Mines Ltd dismissed Yusufali & Associates, LLC as its auditor.

“On October 26, 2024, Registrant (the "Company") terminated its engagement with Yusufali & Associates, LLC ("Yusufali & Associates") as the Company's independent registered public accounting firm.”

Edward Cong Wang resigned as Director at Greenland Mines Ltd.

“On August 25, 2024, Edward Cong Wang resigned as a member of the Company’s Board of Directors.”

Peter Moriarty was appointed as Chief Operating Officer at Greenland Mines Ltd.

“Also on August 15, 2024, Peter Moriarty was appointed as the Company’s Chief Operating Officer.”

Jeffrey LeBlanc was appointed as Chief Financial Officer at Greenland Mines Ltd.

“On August 15, 2024, Jeffrey LeBlanc was appointed as the Company’s Chief Financial Officer.”

Edward Cong Wang resigned as interim Chief Financial Officer at Greenland Mines Ltd.

“On July 30, 2024, Edward Cong Wang, the Company’s interim Chief Financial Officer, resigned from that position.”

Greenland Mines Ltd underwent a change of control involving ANEW Medical, Inc. (closed 2024-06-21).

“On June 21, 2024 (the “Closing Date”), Merger Sub merged with and into ANEW, with ANEW continuing as the surviving corporation and as a wholly owned subsidiary of Redwoods (the “Business Combination”).”

Greenland Mines Ltd entered into Non-Redemption Agreement with certain investors named therein (each, a Backstop Investor) (effective 2024-05-09).

“On May 9, 2024, Redwoods Acquisition Corp. (“ RWOD ” or “ Redwoods ”) entered into a non-redemption agreement (the “ Non-Redemption Agreement ”) with certain investors named therein (each, a “ Backstop Investor ”), each acting on behalf of certain funds, investors, entities or accounts that are managed, sponsored or advised by each such Backstop Investor or its affiliates.”

Greenland Mines Ltd shareholders approved Proposal 6 - approval for purposes of Nasdaq Listing Rule 5635(a) and (b) of issuance of more than 20% of common stock and resulting change in control in connection with the Transactions at the 2024-04-12 meeting.

“Proposal 6- A proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(a) and (b), the issuance of more than 20% of the issued and outstanding Company common stock and the resulting change in control in connection with the Transactions 4,185,875 3,152 0”

Greenland Mines Ltd shareholders approved Proposal 5 - election of five directors to serve on the combined company's board effective as of closing at the 2024-04-12 meeting.

“Proposal 5- A proposal to elect five directors to serve on the combined company's board of directors effective as of the closing of the transactions in accordance with the Business Combination Agreement. NOMINEE FOR WITHHELD 5a) Joseph Sinkule 4,138,720 50,307 5b) Shalom Z. Hirschman 4,189,023 4 5c) Samuel Zentman 4,189,023 4 5d) Jon W. McGarity 4,189,023 4 5e) Edward Cong Wang 4,189,023 4”

Greenland Mines Ltd shareholders approved Proposal 4 - adoption of ANEW MEDICAL, INC. 2023 Stock Incentive Plan at the 2024-04-12 meeting.

“Proposal 4- A proposal to adopt the ANEW MEDICAL, INC. 2023 Stock Incentive Plan, and the material terms thereof, including the authorization of the initial share reserve thereunder. 4,135,672 53,355 0”

Greenland Mines Ltd shareholders approved Proposal 3 - non-binding advisory approval of certain governance provisions in the second amended and restated certificate of incorporation at the 2024-04-12 meeting.

“Proposal 3- A proposal to approve, on a non-binding advisory basis, certain governance provisions in the second amended and restated certificate of incorporation, presented separately in accordance with the United States Securities and Exchange Commission ("SEC") requirements 4,135,672 53,355 0”

Greenland Mines Ltd shareholders approved Proposal 2 - approval and adoption of second amended and restated certificate of incorporation at the 2024-04-12 meeting.

“Proposal 2- A proposal to approve and adopt the second amended and restated certificate of incorporation. 4,135,672 53,355 0”

Greenland Mines Ltd shareholders approved Proposal 1 - approval of the business combination, including adopting the Business Combination Agreement and approving the other transactions at the 2024-04-12 meeting.

“Proposal 1 - A proposal to approve the business combination, including (a) adopting the Business Combination Agreement and (b) approving the other transactions contemplated by the Business Combination Agreement and related agreements. 4,185,975 3,052 0”

Greenland Mines Ltd: Amended charter to extend business combination deadline from December 4, 2023 to December 4, 2024, with up to twelve monthly extensions at $35,000 each (effective 2023-11-13).

“the Charter Amendment is attached to this Current Report on Form 8-K as Exhibit 3.1 and is incorporated herein by reference. Item 5.07. Submissions of Matters to a Vote of Security Holders. On November 13, 2023, RWOD held a special meeting of stockholders (the “ Special Meeting ”).”

Greenland Mines Ltd shareholders approved Proposal to amend RWOD's Amended and Restated Certificate of Incorporation to allow RWOD to extend the date by which RWOD must consummate a business combination up to twelve (12) times for an additional one month each time from December 4, 2023 (the date that is 20 months from the closing date of RW at the 2023-11-13 meeting.

“On November 13, 2023, RWOD held a special meeting of stockholders (the " Special Meeting "). On October 19, 2023, the record date for the Special Meeting, there were 8,801,650 issued and outstanding shares of RWOD's common stock (the " Common Stock ") entitled to vote at the Special Meeting, 84.00 % of which were represented in person or by proxy. The final results for RWOD of the matters submitted to a vote of RWOD's stockholders at the Special Meeting are as follows: Matters Voted On For Against Abstain Proposal to amend (the " Extension Amendment ") RWOD's Amended and Restated Certificate of Incorporation to allow RWOD to extend the date by which RWOD must consummate a business combination up to twelve (12) times for an additional one month each time (the " Extension ") from December 4, 2023 (the date that is 20 months from the closing date of RWOD's initial public offering (the " IPO ")) (the " Amended Date ") to December 4, 2024 (the date that is 32 months from the closing date of”

Greenland Mines Ltd amended IMTA Amendment with Continental Stock Transfer & Trust Company (effective 2023-11-13).

“Redwoods Acquisition Corp. (“ RWOD ”) and Continental Stock Transfer & Trust Company entered into an amendment, dated November 13, 2023, to the Investment Management Trust Agreement, dated March 30, 2022, by and between Continental Stock Transfer & Trust Company and RWOD (the “ IMTA Amendment ”).”

Greenland Mines Ltd entered into Note with Redwoods Capital LLC valued at $120,000 (effective 2023-09-23).

“On September 23, 2023, Redwoods Acquisition Corp. (“RWOD”) issued an unsecured, non-interest bearing promissory note in the principal amount of $120,000 (the “ Note ”) to Redwoods Capital LLC, RWOD’s sponsor.”

Greenland Mines Ltd entered into Business Combination Agreement with ANEW MEDICAL, INC. (effective 2023-05-30).

“On May 30, 2023, Redwoods Acquisition Corp., a Delaware corporation (the “ Company ” or “ Redwoods ”), entered into a business combination agreement (the “ Business Combination Agreement ”) by and among the Company, ANEW MEDICAL SUB, INC., a Wyoming corporation (“ Merger Sub ”), and ANEW MEDICAL, INC., a Wyoming corporation (“ ANEW ”).”

Greenland Mines Ltd received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“May 24, 2023, Redwoods Acquisition Corp. (the “Company”) received a delinquency notification letter (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) due to the Company’s non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of the Company’s failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 (the “Form 10-Q”). The Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the”

Greenland Mines Ltd shareholders approved Proposal to amend the Investment Management Trust Agreement to allow RWOD to extend the date on which the Trustee must liquidate the trust account at the 2023-03-31 meeting.

“Proposal to amend the Investment Management Trust Agreement, dated March 30, 2022, by and between RWOD and Continental Stock Transfer & Trust Company (the "Trustee"), to allow RWOD to extend the date on which the Trustee must liquidate the trust account established by RWOD in connection with the IPO (the "trust account") if RWOD has not completed its initial business combination, from April 4, 2023 (the date that is 12 months from the closing date of the IPO) to July 4, 2023 (the date that is 15 months from the closing date of the IPO) and on a monthly basis up to five times from the Amended Date to December 4, 2023 (the date that is 20 months from the closing date of the IPO) by depositing into the trust account $360,000 for the initial three-month Extension and $120,000 per month for each subsequent one-month Extension 11,728,754 1,185,182 0”

Greenland Mines Ltd shareholders approved Proposal to amend RWOD's Amended and Restated Certificate of Incorporation to extend the date by which RWOD must consummate a business combination at the 2023-03-31 meeting.

“Proposal to amend RWOD's Amended and Restated Certificate of Incorporation to allow RWOD to extend the date by which RWOD must consummate a business combination (the "Extension") from April 4, 2023 (the date that is 12 months from the closing date of RWOD's initial public offering of units (the "IPO")) to July 4, 2023 (the date that is 15 months from the closing date of the IPO) (the "Amended Date") and on a monthly basis up to five times from the Amended Date to December 4, 2023 (the date that is 20 months from the closing date of the IPO) 11,728,754 1,185,182 0”

Greenland Mines Ltd entered into Promissory Note with Redwoods Capital LLC valued at Unsecured, non-interest bearing promissory note in principal amount of $360,000 (effective 2023-03-30).

“On March 30, 2023, RWOD issued an unsecured, non-interest bearing promissory note in the principal amount of $360,000 (the “ Note ”) to Redwoods Capital LLC, RWOD’s sponsor.”

Greenland Mines Ltd amended Investment Management Trust Agreement Amendment with Continental Stock Transfer & Trust Company valued at Amendment to Investment Management Trust Agreement dated March 30, 2022 (effective 2023-04-04).

“Redwoods Acquisition Corp. (“ RWOD ”) and Continental Stock Transfer & Trust Company entered into an amendment, dated April 4, 2023, to the Investment Management Trust Agreement, dated March 30, 2022, by and between Continental Stock Transfer & Trust Company and RWOD (the “ IMTA Amendment ”).”

Greenland Mines Ltd entered into Unsecured, Non-Interest Bearing Promissory Note with Redwoods Capital LLC valued at $150,000 (effective 2023-03-22).

“On March 22, 2023, Redwoods Acquisition Corp. (the “ Company ”) issued an unsecured, non-interest bearing promissory note in the principal amount of $150,000 (the “ Note ”) to Redwoods Capital LLC, the Company’s sponsor.”